People · Operator
Named in public records as an officer, director or promoter · active 2019–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Instil Bio, Inc. | — | Biotechnology | Series D+ | $381.2M | $6.5B | 2019 |
| Causeway Therapeutics Ltd | — | Biotechnology | Series A | $14.3M | $147.5M | 2023 |
Neil Gibson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Neil Gibson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jack Nielsen | 1 | 13 |
| Christopher Jones | 1 | 9 |
| Declan Doogan | 1 | 6 |
| Sandeep Laumas | 1 | 6 |
| Mariam Morris | 1 | 2 |
| Margo Roberts | 1 | 2 |
| Gwen Binder | 1 | 1 |
| Nimish Shah | 1 | 1 |
| Kent McGaughy | 1 | 1 |
| Bronson Crouch | 1 | 1 |
| George Matcham | 1 | 1 |
| Robert Hawkins | 1 | 1 |
| Gregor Caldow | 1 | 1 |
| Neal Millar | 1 | 1 |
| David Armour | 1 | 1 |
| Alexander Picket | 1 | 1 |
| Derek Gilchrist | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.